[{"AccountsPayableCurrent_0_Q2_USD":44029.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-260960.0,"NetIncomeLoss_1_Q2_USD":-31803898.0,"NetIncomeLoss_2_Q2_USD":-31840315.0,"NonoperatingIncomeExpense_1_Q2_USD":-31604244.0,"NonoperatingIncomeExpense_2_Q2_USD":-31604244.0,"NotesPayableRelatedPartiesClassifiedCurrent_0_Q2_USD":84433.0,"OperatingIncomeLoss_1_Q2_USD":-199654.0,"OperatingIncomeLoss_2_Q2_USD":-236071.0,"OtherDeferredCostsNet_0_Q2_USD":70000.0,"PaymentsOfFinancingCosts_2_Q2_USD":11551066.0,"PaymentsToAcquireInvestments_2_Q2_USD":552000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"PreferredStockSharesIssued_0_Q2_shares":null,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-552000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":null,"PrepaidExpenseCurrent_0_Q2_USD":153351.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":552000000.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":13040000.0,"ProceedsFromIssuanceOfWarrants_1_Q2_USD":46248532.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":149000.0,"ProceedsFromRepaymentsOfRelatedPartyDebt_2_Q2_USD":-200000.0,"ProductionTaxExpense_1_Q2_USD":48768.0,"ProductionTaxExpense_2_Q2_USD":84434.0,"ProfitLoss_1_Q2_USD":-31803898.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-31840315.0,"StockholdersEquity_0_Q2_USD":5000003.0,"StockIssued1_2_Q2_USD":25000.0,"StockIssuedDuringPeriodValueOther_1_Q2_USD":-29974962.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q2_USD":-467214520.0,"PreferredStockValue_0_Q2_USD":null,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":553437934.0,"LiabilitiesCurrent_0_Q2_USD":198462.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":553337784.0,"AccruedLiabilitiesCurrent_0_Q2_USD":70000.0,"AdditionalPaidInCapital_0_Q2_USD":36838090.0,"Assets_0_Q2_USD":553337784.0,"AssetsCurrent_0_Q2_USD":1330325.0,"AssetsHeldInTrust_0_Q2_USD":552007459.0,"Cash_0_Q2_USD":1.2,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1176974.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":1176974.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockValue_0_Q2_USD":848.0,"DeferredIncomeNoncurrent_0_Q2_USD":19320000.0,"DerivativeGainLossOnDerivativeNet_1_Q2_USD":-1042104.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":-1042104.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":61604799.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":15356267.0,"Liabilities_0_Q2_USD":81123261.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":15213332.0,"InvestmentIncomeInterest_2_Q2_USD":7459.0,"InterestIncomeOther_2_Q2_USD":7459.0,"InterestIncomeOther_1_Q2_USD":7459.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":153351.0,"TemporaryEquityAggregateAmountOfRedemptionRequirement_0_Q2_USD":46721452.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":44029.0,"GeneralAndAdministrativeExpense_1_Q2_USD":150886.0,"GainLossOnSaleOfDerivatives_2_Q2_USD":-15213332.0,"GainLossOnSaleOfDerivatives_1_Q2_USD":-15213332.0,"FranchisorCosts_2_Q2_USD":84433.0,"FederalDepositInsuranceCorporationPremiumExpense_2_Q2_USD":250000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":15356267.0,"GeneralAndAdministrativeExpense_2_Q2_USD":151637.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":467214520.0,"Ticker":"EQRX","CIK":"1843762","name":"CM LIFE SCIENCES III INC.","OfficialName":"EQRx Inc.  Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2184594115.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]